|
This JAAD article shows that following the first case report of Janus kinase inhibitors (JAKi) use in patients with alopecia areata (AA) in 2014, the proportion of patients with AA totalis/universalis seen in derm clinics increased significantly. This is 8 years before the first JAKi was approved to treat AA.
Dr. Chen, a post-doctoral research fellow at Lahey Hospital and Medical Center and Massachusetts General Hospital, was a 2024 SOCS Observership Award recipient. This award supported his two-week rotation working closely with Dr. Crystal Aguh at Johns Hopkins School of Medicine.
As Dr. Aguh noted, “Isaac was an exceptional rotator, he blended seamlessly into our clinic and displayed a keen interest in conditions affecting skin of color patients.” She explained that three manuscripts arose from their two weeks together, including the JAAD article, as well as two other manuscripts focusing on disparities in access to treatments for patients suffering from alopecia areata and unique presentations of autoimmune hair loss in Black patients.
We extend great appreciation to Dr. Aguh for serving as the mentor in this SOCS Observership and congratulate everyone involved in this vitally important work!
|